Start-up entrée en incubation en 2001.

Founded in 1999, PELVIPHARM is a spin-off from the University of Versailles-Saint-Quentin-en-Yvelines (France) relying on multi-disciplinary talents (medical doctor, pharmaco-economist, veterinarian, pharmacists and PhDs) who deliver both high quality academic standards and reliablecontract research services :

•    Preclinical studies based on validated efficacy models including delivery of protocol development, study conduct, report, communication and peer-reviewed publication

•    Guidance for selection of new chemical entities including testing with targeted assays according to potential mechanisms of action

•    Identification of new properties or attributes supporting differentiation of medications within 

the class or between classes
•    Advice in clinical development for new therapeutic indications or enhancements to address unmet medical need or significant commercial opportunities